DIAGNOSTIC ANTIBODIES targeting important immunohistochemistry markers. These indicatively include the following
- Cytokeratins, Type I and Type II
- Transcription Factors, PAX5, P63, GATA3
- Membrane Receptors, c-erbB-2
- Cell proliferation, Ki 67, PDX1
- Hormone Receptors, Estrogen, Progesterone
- Cell Adhesion, CD56
- Growth regulation, PAX8
- Cancer, TTF-1, P40
- Chromatin Remodeller, ATRX
THERAPEUTIC ANTIBODIES both biosimilar and novel, targeting molecules proven successful in combating major diseases, some of which indicatively are:
- Rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, etc. TNF-a
- Wide range of cancers including melanoma, non-small cell lung cancer, and others, PD-1
- HER2-positive breast cancer, gastric cancer, HER2
- Allergic diseases IL-4Ra
- Rare diseases like PNH, aHUS, and generalized myasthenia gravis, C5 complement protein
- Various cancers, including colorectal, lung, and kidney, VEGF
- Non-Hodgkin lymphoma, chronic lymphocytic leukemia, autoimmune diseases, CD20
- Rheumatoid arthritis, systemic juvenile idiopathic arthritis, and cytokine storm (e.g. COVID-19), IL-6R